Clinical Trial Update: Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atorvastatin as prophylaxis for graft-versus-host disease in allogeneic hematopoietic cell transplantation has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Mehdi Hamadani | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-05-15